World Heart Day is proud to partner with the Boehringer Ingelheim and Lilly Alliance, Servier and Arawana.
Our global partners help us tirelessly in our movement to reduce cardiovascular disease (CVD) around the world.
This World Heart Day, we’ve joined forces to make World Heart Day more powerful than ever. With their support, we are raising awareness and encouraging individuals, families, communities and governments to drive the CVD agenda and help people live longer, better, more heart-healthy lives.
Thank you to our official global partners for World Heart Day, for their collaboration.
The Boehringer Ingelheim and Lilly Alliance are driven to transform care for people with cardio-renal-metabolic conditions, a group of interconnected disorders that affect more than one billion people worldwide and are a leading cause of death.
The cardiovascular, renal and metabolic systems are interconnected, and share many of the same risk factors and pathological pathways along the disease continuum. Dysfunction in one system may accelerate the onset of others, resulting in progression of interconnected diseases such as type 2 diabetes, cardiovascular disease, heart failure, and kidney disease, which in turn leads to an increased risk of cardiovascular death. Conversely, improving the health of one system can lead to positive effects throughout the others.
This World Heart Day, they are proud to continue to support the World Heart Federation. Through their research and treatments, their goal is to support people’s health, restoring the balance between the interconnected cardio-renal-metabolic systems and reducing their risk of serious complications. As part of their commitment to those whose health is jeopardized by cardio-renal-metabolic conditions, they will continue embracing a multidisciplinary approach towards care and focusing our resources on filling treatment gaps.
Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2021, Servier employs 21,800 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient’s voice at the heart of its activities, from research to support beyond the pill.
A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neurosciences and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.
Over the years, Arawana has been adhering to the four business concepts of integrity, innovation, quality and service, paying attention to everyone, meeting every taste demand, bringing every sense of safety, and calling on people all over the world to care for cardiovascular health.
Arawana and World Heart Federation will work closely to arouse Chinese people’s attention to cardiovascular health, and by actively carrying out activities to popularize the harm caused by cardiovascular disease to the body and the importance of heart health, pay attention to and help people with high risk of heart disease.
This partnership will actively promote caring for cardiovascular health, expand opportunities for understanding, learning, and sharing cardiovascular prevention and control, and help people achieve a longer and better lives with a focus on health justice and access to heart health care for all.
RT @MediaplanetUK: #CardioHealthCampaign launches today 🤩🔥 you can pick it up inside the @guardian and online at https://t.co/yQW9DAc7FR fe…
about 6 hours ago
#CVD claims more lives globally than any other disease. However, 80% of premature heart attacks and strokes can be… https://t.co/36NPwTVGP5
about 7 hours ago
Today, national stakeholders are meeting for a WHF Roundtable on #CVD and #Diabetes in #Ghana 🇬🇭 using our Roadmap… https://t.co/UdoP0AUhzF
10:42 - 30 March
Cardiovascular disease (CVD) is the leading cause of death in women worldwide 🚨 Stay informed:… https://t.co/2wm1PrnSZH
10:31 - 30 March
RT @GlobalHeartHub: https://t.co/PMLMDybNWM Huge congrats to our patient organisation affiliate @HeartValveVoice on their @worldheartfed aw…
1:27 - 29 March